Narmada Gelatines Ltd
Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]
- Market Cap ₹ 306 Cr.
- Current Price ₹ 505
- High / Low ₹ 530 / 327
- Stock P/E 10.8
- Book Value ₹ 234
- Dividend Yield 1.98 %
- ROCE 27.9 %
- ROE 21.8 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 38.6% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 32.7%
Cons
- The company has delivered a poor sales growth of 9.82% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 134 | 131 | 113 | 118 | 126 | 134 | 135 | 157 | 191 | 182 | 189 | 215 | |
| 113 | 120 | 109 | 112 | 116 | 120 | 127 | 143 | 171 | 161 | 164 | 174 | |
| Operating Profit | 21 | 11 | 4 | 5 | 9 | 14 | 8 | 15 | 20 | 21 | 25 | 41 |
| OPM % | 16% | 8% | 3% | 5% | 7% | 11% | 6% | 9% | 10% | 12% | 13% | 19% |
| 4 | 3 | 6 | 4 | 5 | 6 | 6 | 3 | 2 | 2 | 2 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 |
| Profit before tax | 23 | 13 | 8 | 8 | 13 | 18 | 11 | 15 | 20 | 21 | 23 | 38 |
| Tax % | 34% | 36% | 27% | 5% | 24% | 28% | 26% | 20% | 23% | 26% | 24% | 26% |
| 16 | 8 | 6 | 8 | 10 | 13 | 8 | 12 | 15 | 15 | 17 | 28 | |
| EPS in Rs | 25.62 | 13.70 | 10.10 | 13.29 | 16.63 | 21.29 | 13.98 | 20.40 | 25.26 | 25.34 | 28.45 | 47.01 |
| Dividend Payout % | 14% | 29% | 40% | 30% | 60% | 47% | 72% | 49% | 396% | 39% | 35% | 23% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 10% |
| 3 Years: | 4% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 39% |
| 3 Years: | 26% |
| TTM: | 69% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 21% |
| 3 Years: | 7% |
| 1 Year: | 34% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 14% |
| 3 Years: | 17% |
| Last Year: | 22% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 98 | 103 | 112 | 118 | 125 | 130 | 133 | 139 | 88 | 103 | 113 | 135 |
| 1 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 13 | 8 | |
| 15 | 17 | 21 | 16 | 22 | 24 | 26 | 25 | 23 | 25 | 27 | 26 | |
| Total Liabilities | 120 | 128 | 140 | 140 | 155 | 161 | 165 | 170 | 117 | 134 | 159 | 175 |
| 23 | 23 | 22 | 25 | 24 | 26 | 29 | 27 | 28 | 27 | 33 | 41 | |
| CWIP | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 7 | 5 |
| Investments | 27 | 34 | 45 | 53 | 68 | 65 | 50 | 48 | 4 | 10 | 41 | 41 |
| 70 | 72 | 73 | 62 | 61 | 69 | 85 | 94 | 85 | 97 | 78 | 87 | |
| Total Assets | 120 | 128 | 140 | 140 | 155 | 161 | 165 | 170 | 117 | 134 | 159 | 175 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 7 | 7 | 9 | 12 | 5 | 3 | 2 | 14 | 15 | 17 | 25 | |
| -0 | -7 | -2 | -2 | -5 | -4 | 6 | 10 | 44 | -12 | -29 | -13 | |
| -3 | -2 | -5 | -3 | -1 | -9 | -7 | -6 | -67 | -0 | 5 | -12 | |
| Net Cash Flow | 3 | -2 | 0 | 4 | 6 | -8 | 2 | 6 | -9 | 2 | -6 | -0 |
| Free Cash Flow | 6 | 6 | 7 | 4 | 11 | 1 | -0 | 2 | 12 | 13 | 2 | 15 |
| CFO/OP | 66% | 99% | 246% | 208% | 152% | 58% | 96% | 42% | 101% | 90% | 92% | 79% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 41 | 47 | 52 | 59 | 56 | 55 | 48 | 36 | 37 | 44 | 48 | 49 |
| Inventory Days | 194 | 169 | 192 | 144 | 144 | 166 | 166 | 185 | 152 | 161 | 155 | 156 |
| Days Payable | 21 | 23 | 52 | 40 | 62 | 63 | 62 | 57 | 42 | 50 | 57 | 39 |
| Cash Conversion Cycle | 214 | 193 | 193 | 163 | 138 | 158 | 152 | 164 | 147 | 155 | 146 | 166 |
| Working Capital Days | 117 | 120 | 146 | 127 | 95 | 108 | 115 | 119 | 97 | 103 | 88 | 104 |
| ROCE % | 21% | 12% | 4% | 5% | 7% | 11% | 5% | 10% | 16% | 20% | 20% | 28% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| DCP share of net sales % |
|
|||||||||
| Gelatine share of net sales % |
||||||||||
| Export share of net sales % |
||||||||||
| Top 10 customers share of TOI % |
||||||||||
| DCP sales volume growth % YoY |
||||||||||
| Gelatine sales volume growth % YoY |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
1d - Company received Regulation 74(5) certificate for quarter ended June 30, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Newspaper Advertisement -Notice to shareholders regarding transfer of shares to IEPF Authority, which remain unclaimed for the period of seven years, pursuant to the provisions …
-
Closure of Trading Window
25 Jun - Trading window closes from 1 July 2026 until 48 hours after Q1 FY27 results.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
26 May - Filed Annual Secretarial Compliance Report for FY2026; no non-compliances reported.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
26 May - Intimation of Newspaper Publication-Extracts of Audited Standalone and Consolidated Financial Results of the Company for the quarter & year ended 31st March, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company is engaged in the manufacture
of ossein and gelatin. It is located at Jabalpur
and has access to its main and essential
inputs of crushed bones, acid, lime and
water